Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Preferred Shares (2016 - 2021)

Vistagen Therapeutics' Preferred Shares history spans 9 years, with the latest figure at $2300.0 for Q3 2021.

  • For Q3 2021, Preferred Shares changed 0.0% year-over-year to $2300.0; the TTM value through Sep 2021 reached $2300.0, changed 0.0%, while the annual FY2021 figure was $2300.0, 0.0% changed from the prior year.
  • Preferred Shares for Q3 2021 was $2300.0 at Vistagen Therapeutics, roughly flat from $2300.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $2300.0 in Q4 2017 and bottomed at $500.0 in Q3 2017.
  • The 5-year median for Preferred Shares is $1200.0 (2017), against an average of $1575.0.
  • The largest annual shift saw Preferred Shares soared 360.0% in 2017 before it crashed 78.26% in 2018.
  • A 5-year view of Preferred Shares shows it stood at $2300.0 in 2017, then plummeted by 78.26% to $500.0 in 2018, then soared by 140.0% to $1200.0 in 2019, then surged by 66.67% to $2000.0 in 2020, then rose by 15.0% to $2300.0 in 2021.
  • Per Business Quant, the three most recent readings for VTGN's Preferred Shares are $2300.0 (Q3 2021), $2300.0 (Q1 2021), and $2000.0 (Q4 2020).